BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25306799)

  • 1. Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
    Nasr J; Ammoury A; Chouairy C; Mégarbané H; El Habr C
    J Med Liban; 2014; 62(3):176-9. PubMed ID: 25306799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
    Nguyen JK; Koshelev MV; Gill BJ; Boulavsky J; Diwan AH; Dao H
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.
    Pereira AR; Moura LH; Pinheiro JR; Pasin VP; Enokihara MM; Porro AM
    An Bras Dermatol; 2016; 91(5 suppl 1):35-38. PubMed ID: 28300888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Adler NR; McLean CA; Aung AK; Goh MS
    Clin Exp Dermatol; 2017 Apr; 42(3):299-302. PubMed ID: 28084616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    Adachi M; Adachi T; Yokota M; Ichimura C; Yoshida K; Ishii K; Ishiko A
    J Dermatol; 2021 Dec; 48(12):e610-e611. PubMed ID: 34561902
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
    Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
    Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Dellavalle RP; Burch JM; Tayal S; Golitz LE; Fitzpatrick JE; Walsh P
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S56-7. PubMed ID: 12734475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.
    Prieto-Barrios M; Velasco-Tamariz V; Tous-Romero F; Burillo-Martinez S; Zarco-Olivo C; Rodriguez-Peralto JL; Ortiz-Romero PL
    Br J Dermatol; 2018 Mar; 178(3):786-789. PubMed ID: 28222222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
    Garel B; Ingen-Housz-Oro S; Afriat D; Prost-Squarcioni C; Tétart F; Bensaid B; Bara Passot C; Beylot-Barry M; Descamps V; Duvert-Lehembre S; Grootenboer-Mignot S; Jeudy G; Soria A; Valnet-Rabier MB; Barbaud A; Caux F; Lebrun-Vignes B
    Br J Clin Pharmacol; 2019 Mar; 85(3):570-579. PubMed ID: 30511379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Induced Linear IgA Bullous Dermatosis Mimicking Stevens-Johnson Syndrome Treated With Etanercept: A Case Report.
    Kwinta BD; Queen D; Husain S; Gallitano SM
    Am J Dermatopathol; 2023 Mar; 45(3):189-191. PubMed ID: 36729131
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis.
    Mofid MZ; Costarangos C; Bernstein B; Wong L; Munster A; Nousari HC
    J Burn Care Rehabil; 2000; 21(3):246-7. PubMed ID: 10850906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-negative direct immunofluorescence testing in vancomycin-induced linear IgA bullous dermatosis: a diagnostic pitfall.
    Winn AE; Spillane EL; Peterson DJ; Sperling LC; Meyerle JH
    J Cutan Pathol; 2016 Sep; 43(9):802-4. PubMed ID: 27354289
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephalosporin-induced linear IgA dermatosis in a child: Case report and literature review.
    Sarikaya Solak S; Ficicioglu S
    Dermatol Ther; 2019 Jul; 32(4):e12927. PubMed ID: 30977941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Hughes AP; Callen JP
    Dermatology; 2001; 202(2):138-9. PubMed ID: 11306837
    [No Abstract]   [Full Text] [Related]  

  • 17. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
    Kakar R; Paugh H; Jaworsky C
    Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced linear IgA bullous dermatosis in a patient with a vancomycin-impregnated cement spacer.
    Riemenschneider K; Diiorio DA; Zic JA; Livingood MR; Fine JD; Powers JG; Zwerner JP; Tkaczyk E
    Cutis; 2018 Apr; 101(4):293-296. PubMed ID: 29763476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blister fluid is a useful diagnostic tool for diagnosis of vancomycin-induced linear IgA bullous dermatosis.
    Yoshida K; Yoshihama E; Morii K; Ishiko A
    J Dermatol; 2021 Nov; 48(11):e543-e544. PubMed ID: 34368986
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
    Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.